Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration HHS
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA
Performance Review
 

Clinical Measures for Ryan White Part C: Early Intervention Services

 

HIV Clinical Performance Measure: # 8
Stated Performance Measure:Percentage of new clients with HIV infection who had been screened for substance abuse (alcohol & drugs)
Numerator:

Number of clients with HIV infection who:

  • initiated care with the grantee during the measurement year, and
  • had 2 or more medical visits with the grantee during the measurement year, and
  • were screened for substance abuse during the measurement year[1]
Denominator:

Number of clients with HIV infection who:

  • initiated care with the grantee during the measurement year, and
  • had 2 or more medical visits with the grantee during the measurement year
Data Sources:
  • Electronic Medical Record/Electronic Health Record
  • CAREWare, Lab Tracker, or other electronic data base. HIVQUAL reports on this measure for grantee under review
  • Medical record data abstraction by grantee of a sample of records that is negotiated with the OPR Review Team.
National Goals, Targets, or Benchmarks for Comparison
  • IHI Goal: 90%[2]
  • National HIVQUAL Performance Data:[3]

     
    2003
    2004
    2005
    Top 10%
    100%
    100%
    100%
    Top 25%
    99.4%
    100%
    100%
    Median*
    93.0%
    95.6%
    96.7%

    *from HAB data base
Basis for Selection:

Patients living with HIV infection must often cope with multiple social, psychiatric, and medical issues.

US Public Health Guidelines:
“Patients living with HIV infection must often cope with multiple social, psychiatric, and medical issues. Thus, the evaluation [of each patient initially entering care] should also include assessment of substance abuse, economic factors, social support, mental illness, co-morbidities, and other factors that are known to impair the ability to adhere to treatment and to alter outcomes.

Patient factors clearly associated with the risk of decreased adherence - such as active substance abuse, depression, and lack of social support - need to be addressed with patients before initiation of antiretroviral therapy."[4] (10/10/06)

References/Notes:
1 A substance use screen includes documentation of a discussion of substance use, past and current, in the HIV primary care record.
2 IHI Measure reads, “Percent of Patients/Clients Assessed for Substance Use and/or Tobacco Use in the Past 12 Months”
(http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientsClientsAssessedforSubstanceUseandorTobaccoUseinthePast12Months.htm)
3 (http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf)
4 Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (p. 13) (http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf)